Literature DB >> 26573319

What Factors Influence the Success of Medial Gastrocnemius Flaps in the Treatment of Infected TKAs?

Matthew W Tetreault1, Craig J Della Valle2, Daniel D Bohl1, Sameer J Lodha1, Debdut Biswas1, Robert W Wysocki1.   

Abstract

BACKGROUND: Soft tissue defects after TKA are a potentially devastating complication. Medial gastrocnemius flaps occasionally are used to provide soft tissue coverage, most commonly with a periprosthetic joint infection. QUESTIONS/PURPOSES: We asked: (1) What were the rates of persistent or recurrent infection, implant survivorship, flap-related complications, and reoperation for patients who underwent medial gastrocnemius flap reconstruction for soft tissue coverage after TKA? (2) What were the Knee Society clinical and functional scores for patients who underwent medial gastrocnemius flap reconstruction for soft tissue defects after TKA? (3) What were the risk factors for failure of medial gastrocnemius flap reconstruction after TKA, with failure defined as recurrent or new periprosthetic joint infection or inability to reimplant the TKA prosthesis?
METHODS: Between 2003 and 2011, four surgeons at one institution performed 31 medial gastrocnemius flaps for soft tissue coverage over an infected TKA. Of those, 27 (87%) were available for followup at a minimum of 2 years (mean, 4 years; range, 2-6 years), although patients experiencing complications or treatment failures before two years were included. The study group consisted of 15 men and 12 women with a mean age of 61 years at the time of surgery (range, 36-86 years). The general indication for using a gastrocnemius flap in this setting was full-thickness soft tissue deficiency over the anterior knee during the course of treatment for concomitant deep infection. Six flaps were performed at prosthetic explantation and antibiotic spacer placement, eight at a spacer exchange, eight at second-stage TKA prosthesis reimplantation, and five at débridement with polyethylene exchange. The decision regarding when during staged treatment to place the flap was based solely on when the soft tissues were deemed insufficient, and not based on a belief that placement at one stage versus another was advantageous. Failure was defined as inability to undergo reimplantation of a TKA prosthesis or recurrence of periprosthetic joint infection. Patient and procedural characteristics were tested for association with failure. Survivorship was calculated by Cox proportional hazards modeling. Outcomes scores were drawn from a longitudinal institutional registry.
RESULTS: Fourteen of 27 (52%) patients had a persistent or recurrent infection; survivorship of the TKA prosthesis at 4 years was 48% (95% CI, 31%-66%). Although there were no flap-related complications, 12 patients had a total of 19 reoperations during the study period. Overall, the mean (± SD) Knee Society knee (38 ± 18 vs 65 ± 20; p < 0.001) and function (20 ± 22 vs 37 ± 25; p = 0.002) scores were improved at most recent followup. No factors were identified as associated with failure when a Bonferroni correction was applied.
CONCLUSIONS: Gastrocnemius flaps were used to address difficult soft tissue defects in this series, in the presence of deep infections; the high proportion of patients experiencing persistent or recurrent infections reflects the case complexity and not necessarily a problem with the flaps. However, this series highlights the need to continue to explore alternative approaches to managing this difficult clinical problem. Future studies should aim to establish an evidence-based reconstructive algorithm, focusing on host, wound, and timing characteristics that may maximize outcomes. LEVEL OF EVIDENCE: Level IV, therapeutic study.

Entities:  

Mesh:

Year:  2015        PMID: 26573319      PMCID: PMC4746180          DOI: 10.1007/s11999-015-4624-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  32 in total

1.  Operative management and outcome of complex wounds following total knee arthroplasty.

Authors:  M Y Nahabedian; M A Mont; J C Orlando; R E Delanois; D S Hungerford
Journal:  Plast Reconstr Surg       Date:  1999-11       Impact factor: 4.730

Review 2.  Wound healing in total joint replacement.

Authors:  R E Jones; R D Russell; M H Huo
Journal:  Bone Joint J       Date:  2013-11       Impact factor: 5.082

3.  Salvage of jeopardized total-knee prosthesis: the role of the gastrocnemius muscle flap.

Authors:  B Greenberg; D LaRossa; P A Lotke; J B Murphy; R B Noone
Journal:  Plast Reconstr Surg       Date:  1989-01       Impact factor: 4.730

4.  The gastrocnemius myocutaneous flap used as a over for the exposed knee prosthesis.

Authors:  R Sanders; T O'Neill
Journal:  J Bone Joint Surg Br       Date:  1981

5.  Management of wounds of exposed or infected knee prostheses.

Authors:  D Casanova; O Hulard; R Zalta; J Bardot; G Magalon
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2001-03

6.  Reconstruction of soft tissue defects following total knee arthroplasty.

Authors:  Adnan Menderes; Cenk Demirdover; Mustafa Yilmaz; Haluk Vayvada; Ali Barutcu
Journal:  Knee       Date:  2002-09       Impact factor: 2.199

7.  The versatile gastrocnemius myocutaneous flap.

Authors:  J B McCraw; J H Fishman; L A Sharzer
Journal:  Plast Reconstr Surg       Date:  1978-07       Impact factor: 4.730

Review 8.  Arthrodesis of the knee.

Authors:  Janet D Conway; Michael A Mont; Hari P Bezwada
Journal:  J Bone Joint Surg Am       Date:  2004-04       Impact factor: 5.284

9.  Infection and sepsis after operations for total hip or knee-joint replacement: influence of ultraclean air, prophylactic antibiotics and other factors.

Authors:  O M Lidwell; E J Lowbury; W Whyte; R Blowers; S J Stanley; D Lowe
Journal:  J Hyg (Lond)       Date:  1984-12

10.  Skin necrosis after total knee arthroplasty.

Authors:  Michael D Ries
Journal:  J Arthroplasty       Date:  2002-06       Impact factor: 4.757

View more
  6 in total

1.  Use of muscular flaps for the treatment of knee prosthetic joint infection: A systematic review.

Authors:  Giuseppe Rovere; Amarildo Smakaj; Sara Calori; Marco Barbaliscia; Antonio Ziranu; Elisabetta Pataia; Giulio Maccauro; Domenico De Mauro; Francesco Liuzza
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25

2.  Hip and Knee Section, Treatment, Surgical Technique: Proceedings of International Consensus on Orthopedic Infections.

Authors:  Moneer M Abouljoud; David Backstein; Andrew Battenberg; Matthew Dietz; Alejo Erice; Andrew A Freiberg; Jeffrey Granger; Adam Katchky; Anton Khlopas; Tae-Kyun Kim; Per Kjaersgaard-Andersen; Kyung-Hoi Koo; Yona Kosashvili; Percia Lazarovski; Jennifer Leighton; Adolph Lombardi; Konstantinos Malizos; Jorge Manrique; Michael A Mont; Marianthe Papanagiotoy; Rafael J Sierra; Nipun Sodhi; John Stammers; Maik Stiehler; Timothy L Tan; Katsufumi Uchiyama; Derek Ward; Anna Ziogkou
Journal:  J Arthroplasty       Date:  2018-10-19       Impact factor: 4.757

3.  Medial Gastrocnemius Flap in the Course of Treatment for an Infection at the Site of a Total Knee Arthroplasty.

Authors:  Matthew W Tetreault; Craig J Della Valle; Michael D Hellman; Robert W Wysocki
Journal:  JBJS Essent Surg Tech       Date:  2017-05-10

Review 4.  A comparison of healing and complication rates between common flaps utilized in total knee arthroplasty: a review of the literature.

Authors:  Akhil A Chandra; Filippo Romanelli; Alex Tang; Luke Menken; Maximilian Zhang; Adam Feintisch; Frank A Liporace; Richard S Yoon
Journal:  Knee Surg Relat Res       Date:  2022-03-26

5.  The Effect of Positive Postdebridement Cultures on Local Muscle Flap Reconstruction of the Lower Extremity.

Authors:  Arjun Kanuri; Neil D O'Kelly; John Shuck; Paul Kim; Karen K Evans; Christopher E Attinger
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-09-05

6.  Effectiveness of circular hexapod external fixation with soft tissue reconstruction in treating severe knee dislocation due to burn scarring: a case report.

Authors:  Koji Nozaka; Naohisa Miyakoshi; Hidetomo Saito; Hiroaki Kijima; Motoki Mita; Yoichi Shimada
Journal:  BMC Musculoskelet Disord       Date:  2020-09-28       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.